Mechanisms of action of EGFR tyrosine kinase receptor incorporated in extracellular vesicles

Mechanisms of action of EGFR tyrosine kinase receptor incorporated in extracellular vesicles

EGFR and some of the cognate ligands extensively traffic in extracellular vesicles (EVs) from different biogenesis pathways. EGFR belongs to a family of four homologous tyrosine kinase receptors (TKRs). This family are one of the major drivers of cancer and is involved in several of the most frequen...

書誌詳細
主要な著者:	Zanetti-Domingues, LC, Martin-Fernandez, ML, Huber, V
フォーマット:	Journal article
言語:	English
出版事項:	MDPI 2020

類似資料

Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles
著者:: Laura C. Zanetti-Domingues, 等
出版事項: (2020-11-01)

Cooperation and interplay between EGFR signalling and extracellular vesicle biogenesis in cancer
著者:: Zanetti-Domingues, LC, 等
出版事項: (2020)

Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer
著者:: Laura C. Zanetti-Domingues, 等
出版事項: (2020-12-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
著者:: Xu H, 等
出版事項: (2019-07-01)

Extracellular Vesicles As Mediators of Resistance to EGFR-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Preclinical Models
著者:: M. Pérez-Capó, 等
出版事項: (2023-11-01)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
著者:: Lihua Huang, 等
出版事項: (2015-09-01)

Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
著者:: Lu Yang, 等
出版事項: (2022-06-01)

Radiation-Induced Tumor-Derived Extracellular Vesicles Combined with Tyrosine Kinase Inhibitors: An Effective and Safe Therapeutic Approach for Lung Adenocarcinoma with EGFR19Del
著者:: Yao Li, 等
出版事項: (2024-12-01)

HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles
著者:: J.-H. Lee, 等
出版事項: (2018-02-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
著者:: Cornelius Hempel, 等
出版事項: (2017-01-01)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
著者:: Igor Makhlin, 等
出版事項: (2019-11-01)

An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation
著者:: Katri Vaparanta, 等
出版事項: (2022-11-01)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
著者:: Tasia Amelia, 等
出版事項: (2022-01-01)

Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression
著者:: Barnabas Irmer, 等
出版事項: (2023-07-01)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
著者:: Aude I. Ségaliny, 等
出版事項: (2015-03-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
著者:: Panupong Mahalapbutr, 等
出版事項: (2024-02-01)

Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer
著者:: Ramya Lakshmi Rajendran, 等
出版事項: (2021-02-01)

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
著者:: Shannon S. Zhang, MD, 等
出版事項: (2022-08-01)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> Mutations
著者:: Kenichi Suda, 等
出版事項: (2021-06-01)

Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure
著者:: Xingyuan Li, 等
出版事項: (2023-10-01)

Mechanisms of receptor tyrosine kinase activation in cancer
著者:: Zhenfang Du, 等
出版事項: (2018-02-01)

Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
著者:: Kinlin L Chao, 等
出版事項: (2012-01-01)

Action Mechanisms of Small Extracellular Vesicles in Inflammaging
著者:: Rocío Mato-Basalo, 等
出版事項: (2022-04-01)

Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors
著者:: Marcin Skrzypski, 等
出版事項: (2017-09-01)

Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
著者:: Keigo Kobayashi
出版事項: (2023-12-01)

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.
著者:: Daniel B Costa, 等
出版事項: (2007-10-01)

EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis
著者:: Xuedi Zhang, 等
出版事項: (2022-11-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
著者:: Zhe Zhang, 等
出版事項: (2019-11-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
著者:: Tim Fischer, 等
出版事項: (2018-01-01)

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation
著者:: K. K. Laktionov, 等
出版事項: (2019-06-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
著者:: Tatsuki Shibuta, 等
出版事項: (2022-06-01)

Proteolytic Cleavage of Receptor Tyrosine Kinases
著者:: Hao Huang
出版事項: (2021-04-01)

Receptor Tyrosine Kinases — Expanding Horizons
著者:: Sassan Hafizi
出版事項: (2014-06-01)

Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain.
著者:: Kenji Hanamura, 等
出版事項: (2017-07-01)

Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers
著者:: Ichiro N. Maruyama
出版事項: (2014-04-01)

In Vitro Activation and Inhibition of Recombinant EGFR Tyrosine Kinase Expressed in Escherichia coli
著者:: Jihene Elloumi-Mseddi, 等
出版事項: (2013-01-01)

Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors
著者:: Nathaniel J. Myall, MD, 等
出版事項: (2025-02-01)

ALGORITHMS FOR MANAGEMENT OF PATIENTS WITH ADVERSE EVENTS ON THERAPY WITH TYROSINE KINASE INHIBITORS EGFR
著者:: D. D. SAKAEVA
出版事項: (2017-06-01)

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
著者:: Soomin Kim, 等
出版事項: (2025-02-01)

The Prediction Of Epidermal Growth Factor Receptor Mutation And Prognosis Of EGFR Tyrosine Kinase Inhibitor By Serum Ferritin In Advanced NSCLC
著者:: Wu Z, 等
出版事項: (2019-10-01)